These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 6246166)
1. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas. Klitzman JM; Brown JP; Hellström KE; Hellström I J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166 [TBL] [Abstract][Full Text] [Related]
2. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens. Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979 [TBL] [Abstract][Full Text] [Related]
3. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens. Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890 [TBL] [Abstract][Full Text] [Related]
4. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus. Carbone G; Pierotti MA; Boiocchi M; De Leo AB; Ballinari D; Radice P; Borrello MG; Meseguer A; Cernuschi A; Parmiani G Cancer Res; 1985 Oct; 45(10):4980-5. PubMed ID: 2992769 [TBL] [Abstract][Full Text] [Related]
5. Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses. Nowinski RC; Klein PA J Immunol; 1975 Nov; 115(5):1261-8. PubMed ID: 170342 [TBL] [Abstract][Full Text] [Related]
6. Common tumor-associated antigens of chemically induced mouse sarcomas expressing murine leukemia virus antigens by primary in vitro sensitization. Saito T Fukuoka Igaku Zasshi; 1984 Mar; 75(3):137-48. PubMed ID: 6088376 [No Abstract] [Full Text] [Related]
7. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response. Stackpole CW; Demsey A Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988 [TBL] [Abstract][Full Text] [Related]
8. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. DeLeo AB; Shiku H; Takahashi T; John M; Old LJ J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class. Nakayama E; Uenaka A; DeLeo AB; Stockert E; Obata Y; Ueda R; Inui Y J Immunol; 1986 May; 136(9):3502-7. PubMed ID: 3007622 [TBL] [Abstract][Full Text] [Related]
10. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis. Basombrío MA; Mayer AM; Pasqualini CD Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461 [TBL] [Abstract][Full Text] [Related]
11. Serological analysis of cell surface antigens on methylcholanthrene-induced mouse sarcomas with antisera produced against the tumors. Tanimoto M; Takahashi T; Nishizuka Y Gan; 1982 Apr; 73(2):184-92. PubMed ID: 6288499 [TBL] [Abstract][Full Text] [Related]
12. Detection of polymorphism in BALB/c leukemia viruses with mouse antisera. Brown JP; Boiocchi M; Nowinski RC J Virol; 1979 Oct; 32(1):345-9. PubMed ID: 94360 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activities of monoclonal antibodies against the envelope proteins of murine leukemia virus. Tam MR; Green WR; Nowinski RC Cancer Res; 1980 Oct; 40(10):3850-3. PubMed ID: 6254643 [TBL] [Abstract][Full Text] [Related]
14. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. Green WR; Nowinski RC; Henney CS J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211 [No Abstract] [Full Text] [Related]
15. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies. Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550 [TBL] [Abstract][Full Text] [Related]
17. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens]. Pasternak L; Pasternak G Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111 [No Abstract] [Full Text] [Related]
18. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas. Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181 [TBL] [Abstract][Full Text] [Related]
19. Immune response of the mouse to the major core protein (p30) of ecotropic leukemia viruses. Nowinski RC; Watson A J Immunol; 1976 Aug; 117(2):693-6. PubMed ID: 59785 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus. Takeda J; Sato Y; Kiyosawa H; Mori T; Yokoya S; Irisawa A; Miyata M; Obara K; Fujita T; Suzuki T; Kasukawa R; Wanaka A Cell Immunol; 2000 Aug; 204(1):11-8. PubMed ID: 11006013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]